- Home
- IVA vs EOI Comparison
IVA vs EOI Comparison
Compare IVA & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- EOI
- Stock Information
- Founded
- IVA 2011
- EOI 2004
- Country
- IVA France
- EOI United States
- Employees
- IVA N/A
- EOI N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- EOI Finance/Investors Services
- Sector
- IVA Health Care
- EOI Finance
- Exchange
- IVA Nasdaq
- EOI Nasdaq
- Market Cap
- IVA 769.0M
- EOI 835.4M
- IPO Year
- IVA 2020
- EOI N/A
- Fundamental
- Price
- IVA $5.27
- EOI $20.81
- Analyst Decision
- IVA Strong Buy
- EOI
- Analyst Count
- IVA 7
- EOI 0
- Target Price
- IVA $16.57
- EOI N/A
- AVG Volume (30 Days)
- IVA 211.2K
- EOI 83.6K
- Earning Date
- IVA 09-29-2025
- EOI 01-01-0001
- Dividend Yield
- IVA N/A
- EOI 7.19%
- EPS Growth
- IVA N/A
- EOI N/A
- EPS
- IVA N/A
- EOI N/A
- Revenue
- IVA $19,929,536.00
- EOI N/A
- Revenue This Year
- IVA N/A
- EOI N/A
- Revenue Next Year
- IVA N/A
- EOI N/A
- P/E Ratio
- IVA N/A
- EOI N/A
- Revenue Growth
- IVA N/A
- EOI N/A
- 52 Week Low
- IVA $2.11
- EOI $14.36
- 52 Week High
- IVA $7.98
- EOI $18.88
- Technical
- Relative Strength Index (RSI)
- IVA 47.78
- EOI 52.12
- Support Level
- IVA $4.96
- EOI $20.30
- Resistance Level
- IVA $5.34
- EOI $21.10
- Average True Range (ATR)
- IVA 0.74
- EOI 0.31
- MACD
- IVA 0.07
- EOI 0.04
- Stochastic Oscillator
- IVA 23.86
- EOI 77.59
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.